➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Boehringer Ingelheim
Dow
Express Scripts
McKesson

Last Updated: March 5, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EPLERENONE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Eplerenone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00082589 The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure Completed Pfizer Phase 4 2004-04-01 The purpose of this study is to determine if eplerenone is effective in the treatment of mild to moderate heart failure
NCT00094302 Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 2006-08-01 The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.
NCT00094302 Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function Completed New England Research Institutes Phase 3 2006-08-01 The purpose of this study is to evaluate the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure hospitalization in patients who have heart failure with preserved systolic function.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Eplerenone

Condition Name

Condition Name for Eplerenone
Intervention Trials
Hypertension 23
Heart Failure 10
Central Serous Chorioretinopathy 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Eplerenone
Intervention Trials
Hypertension 23
Heart Failure 22
Kidney Diseases 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Eplerenone

Trials by Country

Trials by Country for Eplerenone
Location Trials
United States 185
Japan 45
Canada 27
United Kingdom 17
Germany 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Eplerenone
Location Trials
Massachusetts 12
Ohio 11
Tennessee 10
Texas 9
California 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Eplerenone

Clinical Trial Phase

Clinical Trial Phase for Eplerenone
Clinical Trial Phase Trials
Phase 4 36
Phase 3 16
Phase 2/Phase 3 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Eplerenone
Clinical Trial Phase Trials
Completed 45
Recruiting 24
Not yet recruiting 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Eplerenone

Sponsor Name

Sponsor Name for Eplerenone
Sponsor Trials
Pfizer 17
Brigham and Women's Hospital 10
National Heart, Lung, and Blood Institute (NHLBI) 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Eplerenone
Sponsor Trials
Other 138
Industry 38
NIH 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
Colorcon
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.